Literature DB >> 6156025

Commentary: combination chemotherapy of nonseminomatous testicular cancer.

S K Carter, F M Torti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156025     DOI: 10.1007/BF00254025

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  13 in total

1.  Management of choriocarcinoma and related tumors of uterus and testis.

Authors:  M C LI
Journal:  Med Clin North Am       Date:  1961-05       Impact factor: 5.456

2.  Chemotherapy of metastatic germ cell tumors.

Authors:  R B Golbey; T F Reynolds; D Vugrin
Journal:  Semin Oncol       Date:  1979-03       Impact factor: 4.929

3.  Adjuvant chemotherapy in resected nonseminomatous germ cell tumors of testis: stages I and II.

Authors:  D Vugrin; E Cvitkovic; W F Whitmore; R B Golbey
Journal:  Semin Oncol       Date:  1979-03       Impact factor: 4.929

4.  Vinblastine (NSC-49842) and bleomycin (NSC-125066) therapy for disseminated testicular tumors.

Authors:  S C Spigel; C A Coltman
Journal:  Cancer Chemother Rep       Date:  1974 Mar-Apr

5.  Combination chemotherapy in germinal cell tumors.

Authors:  M L Samuels; V J Lanzotti; P Y Holoye; L E Boyle; T L Smith; D E Johnson
Journal:  Cancer Treat Rev       Date:  1976-12       Impact factor: 12.111

6.  Chemotherapy of disseminated germinal tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D.

Authors:  S C Spigel; R L Stephens; C D Haas; H S Jones; D Lehane; T E Moon; C A Coltman
Journal:  Cancer Treat Rep       Date:  1978-01

7.  Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasia.

Authors:  M L Samuels; D E Johnson; P Y Holoye
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

8.  Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.

Authors: 
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

9.  Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.

Authors:  J G Krikorian; J R Daniels; B W Brown; M S Hu
Journal:  Cancer Treat Rep       Date:  1978-10

10.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.